PhRMA Blog
2 FOLLOWERS
Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.
PhRMA Blog
1w ago
A new activist-funded study published in JAMA is fueling misleading rhetoric around the cost of diabetes and anti-obesity medicines ..read more
PhRMA Blog
1w ago
The Inflation Reduction Act already threatens seniors’ access to care. Injecting ICER’s flawed value assessments to an already flawed government decision making about drug payment could further jeopardize patients’ ability to get the lifesaving treatments they need ..read more
PhRMA Blog
1w ago
Medicare beneficiaries are facing greater access restrictions on their lifesaving medicines ..read more
PhRMA Blog
2w ago
Congress should put an end to the exploitation of this important safety-net program and put it back on track for the patients it was meant to assist ..read more
PhRMA Blog
2w ago
Read more about how we can increase access to medicines and improve affordability ..read more
PhRMA Blog
1M ago
As someone who has had family members impacted by serious illness, I know that biopharmaceutical progress in recent decades has improved patient outcomes immensely, helping people enjoy healthier, more fulfilling lives ..read more
PhRMA Blog
1M ago
The 2024 elections are well underway, and we’re continuing to track insights voters are sharing about their priorities and the issues that matter most to them ..read more
PhRMA Blog
1M ago
Today, we are pleased to welcome a guest article from Diane Reinhardt, a Voters for Cures advocate and caregiver to her husband living with Alzheimer’s ..read more
PhRMA Blog
1M ago
As the Colorado Prescription Drug Board continues its affordability reviews, too many crucial issues remain unsolved ..read more
PhRMA Blog
1M ago
Global leaders are having several discussions at the world’s major multilateral organizations (MLOs) which could have a significant impact on American innovation, health outcomes and pandemic preparedness ..read more